| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPT1
|
angiopoietin 1
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AVP
|
arginine vasopressin
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CA12
|
carbonic anhydrase XII
|
|
CA9
|
carbonic anhydrase IX
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD34
|
CD34 molecule
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CDA
|
cytidine deaminase
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTSB
|
cathepsin B
|
|
CTSL
|
cathepsin L
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
DCK
|
deoxycytidine kinase
|
|
DEK
|
DEK proto-oncogene
|
|
DHFR
|
dihydrofolate reductase
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DTYMK
|
deoxythymidylate kinase (thymidylate kinase)
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ETV6
|
ets variant 6
|
|
F10
|
coagulation factor X
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FHIT
|
fragile histidine triad
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXP3
|
forkhead box P3
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAST
|
gastrin
|
|
GATA4
|
GATA binding protein 4
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GNB1L
|
guanine nucleotide binding protein (G protein), beta polypeptide 1-like
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KDR
|
kinase insert domain receptor
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
LACRT
|
lacritin
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR122
|
microRNA 122
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR328
|
microRNA 328
|
|
MIR95
|
microRNA 95
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRP1
|
neuropilin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAX8
|
paired box 8
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PF4
|
platelet factor 4
|
|
PGF
|
placental growth factor
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PQBP1
|
polyglutamine binding protein 1
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRL
|
prolactin
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROKR2
|
prokineticin receptor 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTS
|
6-pyruvoyltetrahydropterin synthase
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCG2
|
secretogranin II
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SNAI2
|
snail family zinc finger 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMED5
|
transmembrane emp24 protein transport domain containing 5
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMS
|
thymidylate synthetase
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|